# Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria

> **NCT00243737** · PHASE2 · COMPLETED · sponsor: **Albert Schweitzer Hospital** · enrollment: 70 (—)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate-Mefloquine

## Key facts

- **NCT ID:** NCT00243737
- **Lead sponsor:** Albert Schweitzer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 70 (—)
- **Last updated:** 2013-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243737, "Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00243737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*